MICHAEL JEFFRIES: Open Payments
NPI 1083163570 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 11 payments from 8 companies in 2025. Trend: 2023 $225 · 2024 $702 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 1 | $72 |
| Kestra Medical Technology Services, Inc. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Novo Nordisk Inc | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $6 |
Products named: Barostim Neo System, Assure WCD, LEQVIO, Ozempic, VERQUVO, ELIQUIS, REPATHA, LifeVest.
Industry payments across MO — which companies pay providers there.
